Posts Tagged ‘current concepts’

Dengue

Posted by Sara Fazio • April 13th, 2012

There are an estimated 50 million infections per year with the dengue virus, which is transmitted primarily by urban adapted Aedes aegypti mosquitoes. The latest review in our Current Concepts series summarizes pathophysiology and treatment as well as prospects for a vaccine and for vector-control approaches. Dengue is a self-limited, systemic viral infection transmitted between humans… Read More…

Dysfunction of the Diaphragm

Posted by Sara Fazio • March 9th, 2012

Dysfunction of one or both hemidiaphragms is an underdiagnosed cause of dyspnea. Weakness or paralysis may be seen during mechanical ventilation, after surgery or trauma, with metabolic or inflammatory disorders, and with myopathy, neuropathy, or diseases causing lung hyperinflation. The latest article in our Current Concepts review series includes videos showing ultrasonography of normal and… Read More…

Nanomedicine

Posted by Graham McMahon • December 17th, 2010

The latest article in our Current Concepts review series, “Nanomedicine,” comes from Drs. Betty Kim, James Rutka, and Warren Chan of the University of Toronto. The field of nanomedicine aims to apply nanotechnology to the diagnosis and treatment of diseases at the molecular level. Clinical Pearls • What do nanomaterials consist of? Nanomaterials generally consist of… Read More…

Influenza Vaccines

Posted by Graham McMahon • November 18th, 2010

The latest article in our Current Concepts series, “Influenza Vaccines for the Future,” comes from Drs. Linda C. Lambert and Anthony S. Fauci of the National Institute of Allergy and Infectious Diseases in Bethesda. Each year, seasonal epidemics of influenza cause serious illness and death throughout the world. In the United States, the annual burden… Read More…

Nonalcoholic Fatty Liver Disease

Posted by Graham McMahon • October 1st, 2010

The latest article in our Current Concepts series, Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease, comes from Drs. Giovanni Targher and Enzo Bonora from the University of Verona, and Dr. Christopher Day from Newcastle University. Approximately 20 to 30% of adults in the general population in Western countries have nonalcoholic fatty… Read More…

Hodgkin’s Survivors

Posted by Graham McMahon • August 13th, 2010

Our latest Current Concepts, Early-Stage Hodgkin’s Lymphoma, comes from Dr. James O. Armitage of the University of Nebraska Medical Center. The treatment of patients with early-stage Hodgkin’s lymphoma is one of the success stories of modern oncology. Today, more than 90% of such patients will survive for at least 5 years after diagnosis. Clinical Pearls •… Read More…